AMPHASTAR PHARMACEUTICALS IN financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $184 | $171 | $192 | $174 | $171 | $191 | $182 | $172 | |
| $30 | $6.4 | $17 | $31 | $25 | $40 | $38 | $43 | |
| $0.67 | $0.14 | $0.37 | $0.64 | $0.51 | $0.78 | $0.73 | $0.81 | |
| 44 | 46 | 48 | 48 | 50 | 52 | 52 | 53 |
Trend